Those views of mine were honed thru two intense decades of professional stock analysis and portfolio manager experience being on the front lines of the investment process beginning with institutional presentations on investing in Japan in the early 1970's to dealing with uncovering hidden value in misunderstood $multi bln multi national industrials to uncovering emerging technology growth co's in the 80's; as well as memorable experiences dealing with successful hedge fund managers on both the long and short side, to even being responsible for a successful proxy contest in unseating a CEO founder of a technology co.
I continue my dedication as a private investor due to being a creature of the markets.I know of no other business that is so challenging and keep one enraptured... if one can keep pace with dynamic change.
Clearly we are dealing with a highly unusual investment vehicle from many perspectives. I was fortunate in exiting NWBO shares the Summer of 2015 due to a strict investment discipline in dramatically reducing equity exposure from a portfolio manager's perspective overruling my love of a stock analyst's perspective due to the confluence of these factors: the longest and most profitable biotech run; the dramatically slowing of the world's most important consumer, the Chinese consumer, in a world of anemic to non existent growth courtesy of the draconian dislocations still plaguing the world caused by the US subprime mortgage exported financial crisis. And I was fortunate in the opportunity to accumulate a large NWBO position below 70 cents. No one can time stock market bottoms consistently. I've only done that a few times.